Yiling Pharmaceutical's Unit Gets Registration Certificate for Qifangbitong Tablets

Published on 2025-01-22 at 02:29 - Modifié on 2025-01-22 at 02:30

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Yiling Pharmaceutical Receives Regulatory Greenlight for Review of Banxia Baizhu Tianma Granules	07-11	MT
Yiling Pharmaceutical Gets Nod to Trial G201-Na Capsule	07-08	MT
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	04-28	CI
Yiling Pharmaceutical's Unit Gets Registration Certificate for Qifangbitong Tablets	01-22	MT
Yiling Pharma Withdraws Plans to Trial Assisted Reproductive Drug	01-08	MT
Yiling Pharmaceutical Unit Gets Nod to Market Simvastatin Tablets in US	12-02	MT
Shijiazhuang Yiling Pharmaceutical's Tongluo Mingmu Capsules Added to National Medical Insurance Catalog	11-29	MT
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	24-10-28	CI
Shijiazhuang Yiling Pharmaceutical Reproduction-Related Drug Gets NMPA's Nod for Clinical Trials	24-10-18	MT
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	24-08-27	CI
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24-04-26	CI
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24-04-26	CI
Yiling Pharmaceutical Gets Nod for China Clinical Trial of Tracheobronchitis Drug	23-12-06	MT
Yiling Pharmaceutical's Lianhua Qingke Tablets Gets Nod to Become Over-the-Counter Drug; Shares Up 4%	23-11-23	MT
Yiling Pharmaceutical Gets Nod to Trial Huoxia Cold Granules	23-11-17	MT
Yiling Pharmaceutical Presents Clinical Data on Cardiovascular Drug at Beijing Conference	23-11-17	MT
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Yiling Pharmaceutical Gets Green Light to Trial Acute Myeloid Leukemia Drug	23-10-24	MT
Yiling Pharmaceutical Gets Greenlight to Trial G201-Na Capsules	23-10-12	MT
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Yiling Pharma's Hypertension Drug Passes Regulatory Evaluation in China	23-05-15	MT
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Yiling Pharma Wins Nod to Trial Prostate Cancer Drug	23-04-05	MT
Yiling Pharma Unit Gets Marketing Rights of Rujietai Capsules	23-03-02	MT
Shijiazhuang Yiling Pharma Appoints Founder as Honorary Chairman	23-02-28	MT